Mikael Andersson Franko works as a Biostatistician at the Department of Clinical Science and Education, Södersjukhuset. His main duties are to contribute statistical expertise in regards to planning, design, and analysis in various research projects conducted at Karolinska Institute. He obtained his PhD in Mathematical Statistics at Chalmers University of Technology in 1995, and he has since been working as a Senior Lecturer in Mathematical Statistics at Stockholm University, at the Swedish University of Agricultural Sciences, and at Rice University in Houston, USA, as well as a Biostatistician at the Swedish Institute for Infectious Disease Control.
Emma Tham is an Associate Professor (Docent) at MMK, Karolinska Institute, and team leader of the "Multi-omics analyses in cancer" team, which is part of the Clinical Genetics group. She is also a Senior Consultant in Clinical Genetics at Karolinska University Hospital. At the clinic, she meets patients with hereditary cancer, and at her clinical laboratory, she analyzes constitutional variants in whole genome sequencing as well as somatic genetic alterations in hematological malignancies.
Tracy A. O’Mara completed her Bachelor of Applied Science (First Class Honours) at the Queensland University of Technology (QUT), researching hormone responses of genes involved in ovarian cancer. She was then employed in an NHMRC-funded research assistant position. In this role, she contributed to studies of prostate cancer and ovarian cancer. She contributed to the first genome-wide association study of prostate cancer published by the international consortium, PRACTICAL. In 2008, she commenced her PhD at QUT, studying the role of common genetic variation on endometrial cancer risk and prognosis. She contributed to the first genome-wide association study of endometrial cancer in 2011. On completion of her PhD, she was awarded an NHMRC Early Career Fellowship to continue her research of endometrial cancer genetics at the QIMR Berghofer. She now leads the Endometrial Cancer Association Consortium, with the goal to discover and characterize genetic variants associated with endometrial cancer risk. In 2020, in recognition of her gynecological cancer research, she was awarded the Cure Cancer Researcher of the Year.
Per Hall started working as a medical oncologist at the Department of Oncology, Karolinska Hospital, after graduation at the University of Lund in 1984. During his sixteen years at Radiumhemmet, he initiated and headed the Hereditary Breast Cancer Unit and later the Cancer Epidemiology Unit. He defended his thesis in the field of Radiation Epidemiology in 1991. He started working as a full-time epidemiologist at the Department of Medical Epidemiology and Biostatistics in 2000. Today, his research focus is on breast cancer prevention and early detection. Since 1996, he has coordinated six European Commission and two NIH projects. Besides the ordinary national funding agencies, he has received funding from private donations and the Stockholm County Council.
